Amgen has a strong product portfolio, pipeline developments, and robust financial health. Read why AMGN stock is a Strong Buy ...

Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...

Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

Zoryve is under clinical development by Arcutis Biotherapeutics and currently in Pre-Registration for Psoriasis.

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...

A mum has issued a warning after her daughter was left wheelchair-bound after playing with slime. M'Layah Chapman had a ...

The mum of a young girl who was left wheelchair-bound after playing with slime has issued a warning to other parents. M'Layah ...

Connect Biopharma (NASDAQ:CNTB – Get Free Report) and Janone (NASDAQ:ALTS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two ...

Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...

Cambridge: Atavistik Bio, a biotechnology company has announced that it has entered into a research collaboration with Pfizer ...

Gaza’s health ministry said that 88 people had been killed over the past day. Israeli and Hamas officials have been holding indirect cease-fire talks via mediators in Qatar. By Hiba Yazbek and ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...